期刊
INTERNATIONAL JOURNAL OF CANCER
卷 134, 期 3, 页码 664-673出版社
WILEY
DOI: 10.1002/ijc.28385
关键词
early-onset cancer survivors; cardiovascular morbidity; late effects
类别
资金
- Finnish Cancer Organizations
- Cancer Association of South-West Finland
- Nona and Kullervo Vare Foundation
- Cancer Foundation Finland sr [120103] Funding Source: researchfish
Improvements in cancer therapy have resulted in an expanding population of early-onset cancer survivors. In contrast to childhood and adolescent cancer survivors, there is still a lack of data concerning late morbidities among young adult (YA) cancer survivors. Thus, our aim was to investigate cardiac and vascular morbidity among early-onset cancer survivors with a special interest in YA cancer survivors. In a population-based setting, we explored the risk of cardiovascular disease in early-onset cancer survivors compared to healthy siblings. Patients diagnosed with cancer below 35 years of age since 1975 were identified from the Finnish Cancer Registry, and 5-year survivors were included in our study (N = 13,860). Information on cardiovascular morbidity was collected from the national hospital discharge registry. Compared to siblings, cancer survivors aged 0-19 and 20-34 at diagnosis had significantly elevated hazard ratios (HRs) for the studied outcomes: HR 13.5 (95% CI 8.9-20.4) and 3.6 (95% CI 2.8-4.6) for cardiomyopathy/cardiac insufficiency; HR 3.4 (95% CI 2.3-5.1) and 1.7 (95% CI 1.4-2.0) for atherosclerosis/brain vascular thrombosis; HR 3.3 (95% CI 1.7-6.5) and 1.8 (95% CI 1.5-2.1) for myocardial infarction/cardiac ischemia and HR 1.7 (95% CI 1.2-2.6) and 1.4 (95% CI 1.2-1.7) for cardiac arrhythmia. In both groups, depending on the outcome, the HR for adverse events was highest among lymphoma, brain tumor, leukemia and testicular malignancy survivors. Our results regarding late effects of childhood cancer survivors confirmed previous findings. Additionally, our study provides novel information concerning the YA cancer survivor population. Hence, our data may help in planning the risk-based long-term follow-up of early-onset cancer survivors. What's new? Long-term survivors of childhood cancer may suffer from the later development of health conditions related to their disease or to the treatment they received, and much effort has been made to better monitor and treat these conditions. Unfortunately, the same advances have not occurred for young adult (YA) cancer survivors, who similar to their younger counterparts are at increased risk of life-threatening vascular complications but lack specific guidelines for long-term follow-up, according to this study. The report suggests that YA cancer survivors could benefit greatly from individualized, follow-up care.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据